Abstract
Low vaccine-effectiveness has been recognised as a key factor undermining efforts to improve strategies and uptake of seasonal influenza vaccination. Aiming to prevent disease transmission, vaccination may influence the perceived risk-of-infection and, therefore, alter the individual-level behavioural responses, such as the avoidance of contact with infectious cases. We asked how the avoidance behaviour of vaccinated individuals changes disease dynamics, and specifically the epidemic size, in the context of imperfect vaccination. For this purpose, we developed an agent-based simulation model, and parameterised it with published estimates and relevant databases for population demographics and agent characteristics. Encapsulating an age-stratified structure, we evaluated the per-contact risk-of-infection and estimated the epidemic size. Our results show that vaccination could lead to a larger epidemic size if the level of avoidance behaviour in vaccinated individuals reduces below that of susceptible individuals. Furthermore, the risk-of-infection in vaccinated individuals, which follows the pattern of age-dependent frailty index of the population, increases for older age groups, and may reach, or even exceed, the risk-of-infection in susceptible individuals. Our findings indicate that low engagement in avoidance behaviour can potentially offset the benefits of vaccination even for vaccines with high effectiveness. While highlighting the protective effects of vaccination, seasonal influenza immunisation programmes should enhance strategies to promote avoidance behaviour despite being vaccinated.
Highlights
Vaccination against seasonal influenza remains a primary public health measure to prevent infection and its outcomes such as hospitalisation and death [1, 2]
The results indicate that there is a sizable domain of vaccine efficacy and contact avoidance by vaccinated individuals that leads to higher epidemic sizes compared to the no-vaccine scenario
Based on a comprehensive agent-based simulation model, we found that a low vaccine efficacy can result in a higher number of infections if vaccinated individuals reduced their level of engagement in behavioural avoidance below that of the susceptible individuals
Summary
Vaccination against seasonal influenza remains a primary public health measure to prevent infection and its outcomes such as hospitalisation and death [1, 2] The impact of this measure, depends on several factors including vaccine coverage and more importantly vaccine effectiveness [3]. The effectiveness of vaccines produced by the conventional egg-based method is subject to virus mutation that can occur both during the production process [4], and during natural infection [5] The occurrence of these mutations during seasonal epidemics enhances the antigenic distance between dominant influenza viruses and the vaccine strains [4], further reducing vaccine effectiveness over the course of an epidemic [6], especially in high-risk individuals and those with a high frailty index [7]. This quantification can help vaccination campaigns to improve communication on the effect of influenza vaccine and the role of other measures including avoidance behaviour to impede disease transmission
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have